Thermo Fisher Scientific Inc (NYSE:TMO) over-valued by 10%
Website | https://www.thermofisher.com/ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Fiscal Year End | Dec 31, 2019 |
Market Cap | $177,168,482,000 |
Beta | 0.98491 |
Average Volume | $1,282,727 |
Last Dividend | 0.79% |
Price on Jul 31, 2020 | $435.06 |
Autochartist™ Valuation | $390.89 |
Conclusion |
10% over-valued |
Download Report |